BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8136456)

  • 1. Analysis of autoantibody reactivity in patients with Graves' disease using recombinant extracellular domain of the human thyrotropin receptor and synthetic peptides.
    Fan JL; Seetharamaiah GS; Desai RK; Dallas JS; Wagle NM; Prabhakar BS
    Autoimmunity; 1993; 15(4):285-91. PubMed ID: 8136456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A region on the human thyrotropin receptor which can induce antibodies that inhibit thyrotropin-mediated activation of in vitro thyroid cell function also contains a highly immunogenic epitope.
    Dallas JS; Seetharamaiah GS; Cunningham SJ; Goldblum RM; Desai RK; Prabhakar BS
    J Autoimmun; 1994 Aug; 7(4):469-83. PubMed ID: 7980849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective binding of thyrotropin receptor autoantibodies to recombinant extracellular domain of thyrotropin/lutropin-chorionic gonadotropin receptor chimeric proteins.
    Seetharamaiah GS; Zhuang J; Huang J; Patibandla SA; Kaithamana S; Tahara K; Kohn LD; Prabhakar BS
    Thyroid; 1999 Sep; 9(9):879-86. PubMed ID: 10524566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides.
    Takai O; Desai RK; Seetharamaiah GS; Jones CA; Allaway GP; Akamizu T; Kohn LD; Prabhakar BS
    Biochem Biophys Res Commun; 1991 Aug; 179(1):319-26. PubMed ID: 1883361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
    Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
    J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides.
    Desai RK; Dallas JS; Gupta MK; Seetharamaiah GS; Fan JL; Tahara K; Kohn LD; Prabhakar BS
    J Clin Endocrinol Metab; 1993 Sep; 77(3):658-63. PubMed ID: 8103771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
    Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.
    Pichurin PN; Chen CR; Nagayama Y; Pichurina O; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2004 Mar; 135(3):391-7. PubMed ID: 15008970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera.
    Chazenbalk GD; Jaume JC; McLachlan SM; Rapoport B
    J Biol Chem; 1997 Jul; 272(30):18959-65. PubMed ID: 9228077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies interacting with purified native thyrotropin receptor.
    Atger M; Misrahi M; Young J; Jolivet A; Orgiazzi J; Schaison G; Milgrom E
    Eur J Biochem; 1999 Nov; 265(3):1022-31. PubMed ID: 10518798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain.
    Soliman M; Kaplan E; Yanagawa T; Hidaka Y; Fisfalen ME; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Mar; 80(3):905-14. PubMed ID: 7533773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
    Park JY; Kim IJ; Lee MH; Seo JK; Suh PG; Cho BY; Ryu SH; Chae CB
    Endocrinology; 1997 Feb; 138(2):617-26. PubMed ID: 9002995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of human thyrotropin receptor produced using baculovirus expression system.
    Seetharamaiah GS; Desai RK; Dallas JS; Tahara K; Kohn LD; Prabhakar BS
    Autoimmunity; 1993; 14(4):315-20. PubMed ID: 8102255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
    Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of mice with Yersinia enterocolitica leads to the induction of antithyrotropin receptor antibodies.
    Luo G; Fan JL; Seetharamaiah GS; Desai RK; Dallas JS; Wagle N; Doan R; Niesel DW; Klimpel GR; Prabhakar BS
    J Immunol; 1993 Jul; 151(2):922-8. PubMed ID: 8335920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.